Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia
Dados Bibliográficos
| ID | 19440034 |
|---|---|
| Autores | Getachew Ebissa, Negusse Deyessa (Addis Ababa University), Sibhatu Biadgilign (0000-0002-7582-5977, autor correspondente) |
| Ano | 2015 |
| Volume | 27 |
| Fascículo | 6 |
| Páginas | 723-730 |
| Data de publicação | 2015-06-03 |
| Peer Reviewed | Sim |
| Open Access | Não |
| Tipo | ARTICLE |
| Periódico | AIDS Care (JOURNAL) |
| Identificadores do periódico | ISSN: 0954-0121 • E-ISSN: 1360-0451 |
| Editora | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.1080/09540121.2014.997180 |
| PMID | 25599414 |
| OpenAlex | W2052514962 |
| Idioma | EN |
| Citações recebidas | 3 |
| Referências citadas | 30 |
Highly active antiretroviral therapy (HAART) is the breakthrough in care and treatment of people living with HIV, leading to a reduction in mortality and an improvement in the quality of life. Without antiretroviral treatment, most HIV-infected children die before their fifth birthday. So the objective of this study is to determine the mortality and associated factors in a cohort of HIV-infected children receiving ART in Ethiopia. A multicentre facility-based retrospective cohort study was done in selected pediatric ART units in hospitals found in Addis Ababa, Ethiopia. The probability of survival was estimated using the Kaplan-Meier method, and multivariate analysis by Cox proportional hazards regression models was conducted to determine the independent predictor of survival. A total of 556 children were included in this study. Of the total children, 10.4% were died in the overall cohort. More deaths (70%) occurred in the first 6 months of ART initiation, and the remaining others were still on follow-up at different hospitals. Underweight (moderate and severe; HR: 10.10; 95% CI: 2.08, 28.00; P = 0.004; and HR: 46.69; 95% CI: 9.26, 200.45; P < 0.01, respectively), advanced disease stage (WHO clinical stages III and IV; HR: 10.13: 95% CI: 2.25, 45.58; P = 0.003), poor ART adherence (HR: 11.72; 95% CI: 1.60, 48.44; P = 0.015), and hemoglobin level less than 7 g/dl (HR: 4.08: 95% CI: 1.33, 12.56; P = 0.014) were confirmed as significant independent predictors of death after controlling for other factors. Underweight, advanced disease stage, poor adherence to ART, and anemia appear to be independent predictor of survival in HIV-infected children receiving HAART at the pediatric units of public hospitals in Ethiopia. Nutritional supplementations, early initiation of HAART, close supervision, and monitoring of patients during the first 6 months, the follow up period is recommended
Antiretroviral therapy · Body mass index · Cohort · Cohort study · Multivariate analysis · Proportional hazards model · Retrospective cohort study · Survival analysis · Underweight · Viral load · HIV Research and Treatment · HIV-related health complications and treatments · HIV/AIDS Research and Interventions · Medicine · Immunology · Internal Medicine · Pediatrics
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
Mortality of infected and uninfected infants born to HIV-infected mothers in Africa
Impact of Adherence and Highly Active Antiretroviral Therapy on Survival in HIV-Infected Patients
Early Antiretroviral Therapy and Mortality among HIV-Infected Infants
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up
Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia
| Obras citantes distintas | 3 |
|---|---|
| Citações por ano | 0,33 |
| Intervalo de citações | 2017 - 2020 (4) |
| Velocidade de citação | historical |
| Altamente citado | Não |
| Tipos de citação | Neutras: 3 |